New research reveals that individuals who discontinue popular weight-loss injections like Wegovy and Mounjaro can put back on shed pounds at a significantly accelerated pace than those who stop conventional diet and exercise plans.
Research printed in a prominent health publication points out that while obese individuals frequently drop a large proportion of their total mass while on the medication, the weight comes back at an average rate of nearly a kilo each month upon discontinuation.
"Individuals using such treatments need to be cognizant of the potential of quick weight regain when the medication is stopped," cautioned expert Dr. Susan Jebb.
Such speed of recovery implies a return to pre-treatment mass in about a year and a half.
Analyzing Treatments
The research, which reviewed 37 of trials involving over 9,000 of participants, compared the outcomes of GLP-1 agonists with conventional dieting.
Researchers point out that individuals who lose weight through lifestyle changes alone generally experience a less rapid weight regain—approximately 100 grams monthly—post-intervention.
Explaining the Quick Rebound
Doctors propose the way of the jabs is key to understanding the accelerated regain.
GLP-1 drugs mimic a body's own chemical called glucagon-like peptide-1, which moderates appetite.
"Artificially providing GLP-1 levels far above than normal could lead to the system to produce less of its endogenous hormone, and could lessen responsiveness to its effects," said Dr. Adam Collins, a dietetics expert.
"Withdrawal of this hormone supplement results in appetite is uncontrolled, making binge eating much more probable."
A Chronic Issue?
Medical guidelines suggest the injections for people with weight-linked health risks, alongside prescribed lifestyle changes.
Professionals contend that, considering the likelihood of relapse, the therapy is often long-term.
This view is echoed by drug manufacturers, who say that the findings "underscore the long-term character of excess weight," comparing it to managing conditions like hypertension.
User Testimonies
Users who have come off the jabs report a sudden resurgence of hunger.
"It felt as if something flipping and you become extremely hungry," said an individual.
The struggle is worsened if users have not developed permanent lifestyle or habit modifications during therapy.
Significant Interest
Recent estimates show that millions of adults in the UK have used weight-loss jabs in the last 12 months, with demand continuing to grow.
- Adoption is greater among females than males.
- The 40s and 50s age group shows the highest usage rates.
- Many obtain the drugs through private prescriptions rather than the NHS.
Ultimately, researchers caution that while GLP-1 drugs are powerful agents for weight loss, they are not a standalone cure and long-term success relies on integrated lifestyle support.
